Your Open Access fees might be covered

Your Open Access fees might be covered

Author Guidelines




Please be advised that the JPCH Editorial Office is currently experiencing some delays in processing submitted manuscripts. We thank you for your submission and will be working to provide you with a timely response.

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting, conference or symposium.

New submissions should be made via the Research Exchange submission portal at Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at any time by logging on to and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Free Format

The Journal of Paediatrics and Child Health offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. If the figures are not of sufficiently high quality, your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • An ORCID ID, freely available at (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
      • data availability statement
      • funding statement
      • conflict of interest disclosure
      • ethics approval statement
      • patient consent statement
      • permission to reproduce material from other sources
      • clinical trial registration

Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, affiliation, and other contact details the publication might require will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at


Journal of Paediatrics and Child Health is the official journal of the Paediatrics and Child Health Division (The Royal Australasian College of Physicians) in affiliation with the Perinatal Society of Australia and New Zealand, the Paediatric Research Society of Australia and the Australasian Association of Paediatric Surgeons, and publishes original research articles of scientific excellence in paediatrics and child health. Research Articles and Editorial Correspondence are published, together with invited Reviews, Annotations, Editorial Comments and manuscripts of educational interest.


Original Article

Word limit: 2,500 words maximum
Abstract: 250 words maximum; structured using sub heads: Aim, Methods, Results, Conclusions. (Abstract must state: The purpose, basic procedures, main findings and principal conclusions of study.)
References: Maximum of 24 references (Vancouver style).
Brief Points: Authors are to provide up to 3 separate points for each Brief Point: ‘What is already known on this topic’ and ‘What this paper adds’.

Brief Communication

Word limit: 600 words maximum
Description: Brief Communications are used to fill gaps in the Journal of Paediatrics and Child Health and will be indexed. They are supposed to be entertaining, humorous, informative, thought-provoking or all of the above. They should be relevant, in a broad sense, to paediatrics and those who work in child health. Examples include humorous or poignant stories or instructive mistakes. Consent will be needed if the subject of the Brief Communication is identifiable.

Letter to the Editor

Word limit: 400 words maximum
Maximum of 4 references (Vancouver style).
Combined maximum of 1 figure/table
Brief summaries of research findings and short case reports can be published as a Letter to the Editor. Please format as a Letter to the Editor as outlined above and remember that Clinical Trials must be registered with the appropriate governing body.

The following article types are by invitation only; however, presubmission enquiries can be directed to [email protected]:


Position Paper

Word limit: 2,500 words maximum
References: Maximum of 50 references (Vancouver style).
Description: Position Papers express the consensus view of an organisation, e.g. about the management of a condition. Any recommendations should be evidence-based and should state the Level of Evidence (using NHMRC criteria).

Review Article

Word limit: 2,500 words maximum
Abstract: 250 words maximum; unstructured or structured using sub heads: Aim, Methods, Results, Conclusions. (Abstract must state: The purpose, basic procedures, main findings and principal conclusions of study.)
References: Maximum of 50 references (Vancouver style).
Key Points: Summarise the main points raised in the manuscript with 3 brief Key Points.

Cochrane Corner

Word limit: 2,500 words maximum
Concise reviews of Cochrane Systematic Reviews. Format: What is the review about?; What are the findings?; What are the findings based on?; Implications for practice; Clinical perspective. Include most relevant Forest plot(s) from Cochrane Review.

The journal is not currently accepting submissions from the following categories:

Case Report

Word limit: 1,200 words maximum
Abstract: No abstract or key words required
References: Maximum of 8 references (Vancouver style).
Figures/Tables: Maximum combined limit of 3 figures/tables
Learning Points: A Summary listing learning points should be included at the end of the Case Report.
Description:  Case Reports are instructive, and involve a clinical problem or issue of clear educational benefit. There is an initial case report, then a brief discussion with learning points and appropriate references.

Case Image

Submit a photograph or image, together with a short clinical question and a brief answer. For an example, please follow these links: Question and Answer. If the photograph is identifiable, please send written permission from a parent and/or child or confirm that verbal approval has been obtained. Privacy is the responsibility of the author(s).


4.1 Original submissions

Journal of Paediatrics and Child Health now offers Free Format submission for a simplified and streamlined submission process. 

Before you submit, you will need:

  • Your manuscript: this can be a single file including text, figures, and tables, or separate files. Your manuscripts must:
    • Contain all required sections, based on the article type (e.g. abstract, introduction, methods, results, and conclusions) and in the correct order. Free Format Submission is not an excuse to submit a disorganised manuscript
    • Include legends for all figures and tables
    • Contain a reference list which is consistent throughout the manuscript
  • Your title page must contain
    • Author details (name, affiliation, email address, see the journal’s authorship policy in the Editorial Policies and Ethical Considerations section for details)
    • An acknowledgment statement
    • A conflict of interest statement
    • An ethics approval statement (if relevant)
    • Patient consent for publication statement (if relevant)
    • Keywords
  • A cover letter
  • The relevant statement/flowchart indicating compliance with the appropriate research guidelines
    • See 'Research Reporting Guidelines', below

If your manuscript is difficult to read, the editorial office may send it back to you for revision.

To submit, log in at and create a new submission. Follow the submission steps as required and submit the manuscript.

4.2 Revised submissions

If you are invited to revise your manuscript after peer review, the journal will also request the revised manuscript to be formatted according to journal requirements as described below.

4.3 Parts of the Manuscript

The manuscript should be submitted in separate files: Title page; main text file; figures.

Title Page

The title page should contain (i) a short informative title that contains the major key words. The title should not contain abbreviations (ii) the type of manuscript (e.g. Original Article, Instructive Case, Editorial Correspondence: Case Note), (iii) the full names of the authors and (iv) the addresses of the institutions at which the work was carried out together with (v) the full postal and email address, plus telephone numbers, of the author to whom correspondence about the manuscript, proofs and requests for offprints should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote. (v) Acknowledgements, (vi) Conflicts of interest.


The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not allowed. This is to be placed in the title page file only for blinding purposes.

Main Text

As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors. The main text of the manuscript should be presented in the following order: (i) Abstract and key words, (ii) text, (iv) references, (v) tables (each table complete with title and footnotes), (vi) figure legends.

Abstract and Key Words

Please refer to the section ‘Manuscript Categories and Requirements’ for details about which article types require abstracts. The abstract should not contain abbreviations or references.

Key words should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list.


Authors should use subheadings to divide the sections of their manuscript: Introduction, Materials and Methods, Results, Discussion.

Figures and Supporting Information should be submitted as separate files. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter. Photos that identify individuals where faces are visible, the eyes must be pixelated or have a coloured bar covering them for privacy.

Reference Style

Manuscripts are to follow the Vancouver style, as detailed in the International Committee of Medical Journal Editors' revised 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication', as presented at

In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited only in tables or figure legends, number them according to the first identification of the table or figure in the text. In the reference list, the references should be numbered and listed in order of appearance in the text.

Cite the names of all authors when there are six or fewer; when there are seven or more list the first three followed by et al.

Names of journals should be abbreviated in the style used in Index Medicus.

Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. A Smith, unpubl. data, 2000).

As this journal offers Free Format submission, however, this is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter.

Journal Article

  1. Soter NA, Wasserman SI, Austen KF. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N. Engl. J. Med. 1976; 294: 687–90.

Online Article not yet Published in an Issue

An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.

  1. Hall A, Jones GV. Effect of potential atmospheric warming on temperature-based indices describing Australian winegrape growing conditions. Aust. J. Grape Wine Res. 2008; (forthcoming).


  1. Kaufmann HE, Baron BA, McDonald MB, Waltman SR, eds. The Cornea. New York: Churchill Livingstone; 1988.

Chapter in a Book

  1. McEwen WK, Goodner IK. Secretion of tears and blinking. In: Davson H, ed. The Eye, vol. 3, 2nd edn. New York: Academic Press; 1969; 34–78.


Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be numbered consecutively in Arabic numerals. Tables should be presented at the end of the article file after the references with a comprehensive but concise legend above the table OR they can be placed into one separate file. Tables should be double-spaced and vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations should be defined in footnotes. Footnote symbols: †, ‡, §, ¶ should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. The table and its legend/footnotes should be understandable without reference to the text.

Preparing Figures

Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions. Do not provide separate files in a zip file, each figure must be uploaded separately as requested.

Do not provide separate files in a zip file. Each figure must be uploaded as a separate file and must be deidentified if there are human subjects included. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Colour figures

Figures submitted in colour will be reproduced in colour online and in the journal issue free of charge.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms and Conditions FAQ.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.


Appendices will be published after the references. For submission they should be supplied as a separate file and referred to in the text as ‘Supporting Information’.

Supporting Information

Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online, and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on Supporting Information.

Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following points provide general advice on formatting and style.

  • Formatting: The main text file should be prepared using Microsoft Word, using 1.5 line spacing.
  • Spelling: The journal uses UK spelling and authors should therefore follow the latest edition of the Concise Oxford Dictionary.
  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
  • Numbers: Numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • Equations: Equations should be numbered sequentially with Arabic numerals; these should be ranged right in parentheses. All variables should appear in italics. Use the simplest possible form for all mathematical symbols.
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health and Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RIIDs in the list of key words associated with the manuscript.

To Obtain Research Resource Identifiers

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled ‘Search Features and Tips’ for more information).
  3. Click on the ‘Cite This’ button to obtain the citation and insert the citation into the manuscript text.

If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the ‘Resource Citation Guidelines’ section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.

Example Citations:

Antibodies: Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411).
Model Organisms: Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304).
Cell lines: Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481).
Tools, Software and Databases: Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (, RRID:nif-0000-00280).

Wiley Author Resources

Manuscript Preparation Tips

Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, we encourage authors to consult Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation and Formatting Support

Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are double-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on the confidentiality of the review process is available here.

MEDLINE evaluates a journal’s ethical policy by checking that journals ask submitting authors to provide three things: a declaration of conflict of interest (CoI), confirmation that informed consent was sought from test subjects, and that animal rights were taken into consideration. The reviewer will then check three things during the review:

  1. Policy Exists: Is there evidence in the author guidelines that the journal requires that the appropriate ethical requirements are followed?
  2. Policy is Adequate: Is the policy appropriate for the journal? E.g. a review journal does not need to have a statement on human/animal rights or informed consent.
  3. Policy Consistently Followed: Is there evidence in all the published articles that authors have declared their conflicts of interest and that appropriate procedures were followed when the research was conducted? This will be checked in the final published articles.

It is recommended that all articles include a statement regarding CoI, regardless of whether or not a CoI exists – for example, ‘The authors have stated explicitly that there are no conflicts of interest in connection with this article.’

There should be robust journal workflows in place to ensure all three criteria are met. Examples of failures would be: a journal that requires authors to declare that institutional review board (IRB) approval was sought for their research, but this is not communicated to the readers of the final article; journals that do require declarations of informed consent, but don't say so in the author guidelines; or journals that only publish statements when conflicts-of-interest were declared, and assume that all readers know omission means that there aren't any conflicts.

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines.

Refer and Transfer Program 

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. When detailed descriptions, photographs, or videos of faces or identifiable body parts are used that may allow identification, authors should obtain the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. Where photographs are used they need to be cropped sufficiently to prevent human subjects being recognized; black eye bars should not be used as they do not sufficiently protect an individual’s identity).

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are required to adhere to recognised research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:

The corresponding statement/flowchart will be required to be uploaded upon submission.

We also encourage authors to refer to and follow guidelines from:

Species Name

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see, where examples of acceptable nomenclature are provided.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Structural Data

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC;
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ;
  • Proteins and nucleic acids: Protein Data Bank (
  • NMR spectroscopy data: BioMagResBank (

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.


Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature:


The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.

JPCH offers dual first authorship. Authors will need to add a footnote to the title page indicating which authors should be displayed as dual first authors.

Author Contributions

For all articles, this journal mandates the CRediT (Contribution Roles Taxonomy)—more information is available on our Author Services site.

Data Sharing and Data Accessibility

The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Human Subject Information in Databases

The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.


This journal requires/encourages ORCID. Please refer to Wiley’s resources on ORCID.

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.


If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)

Self-Archiving Definitions and Policies

Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access Fees

Authors who choose to publish using Open Access will be charged a fee.  For more information on this journal’s APCs, please see the Open Access page. A list of Article Publication Charges for Wiley journals is available here.

Funder Open Access

Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


Accepted Article Received in Production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


Access and Sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • For non-open access articles, the corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Promoting the Article

To find out how to best promote an article, click here.

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.


The Editorial Office, [email protected]